Alternatives to Omzo

Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.

$99/mo semaglutide, $183/mo tirzepatide, all 50 states, a named physician personally reviewing every intake, and a real 5-7 day timeline — on a broader peptide platform where GLP-1 pricing is genuinely invisible unless you know to pull the page's own data bundle.

Flat at every dose - $99 semaglutide, $134 tirzepatide, all fifty states - which makes the annual math trivial. The site never names its operating company.

A fully itemized pricing table — as low as $96/mo semaglutide or $142/mo tirzepatide on the annual plan — from the same medical group behind Cora Health, another new addition this batch.

The most transparently tiered pricing found in this batch — as low as $99/mo semaglutide or $135/mo tirzepatide on the annual plan, with every tier itemized publicly — from a platform with a thin 36-review Trustpilot count so far.

Trellis Vitality is the cheapest genuinely-disclosed option on this page: $150 a month for compounded semaglutide and $199 for tirzepatide, month to month, with every dosage available at the same price and no membership fee, no consult fee and a $0 assessment. Commit for three or six months and those fall to $140/$133 and $189/$179. It names the pharmacy that compounds the medication — Vials Rx, described as a US state-licensed, cGMP-compliant facility — which is the disclosure most of its cheaper competitors skip, and it covers all 50 states with board-certified clinicians reviewing intake. The caveats are about what it doesn't sell and doesn't say. There is no FDA-approved brand option, no oral formulation, and none of its pricing appears on the homepage at all — you have to reach the GLP-1 product page to find a single number, which makes it look more opaque than it actually is. There is also no postpartum, breastfeeding or PCOS content anywhere.

One of the most transparently priced compounded shops in this batch — $230/mo semaglutide or $330/mo tirzepatide month-to-month, down to $120/mo and $170/mo on the annual plan, with an explicit no-membership-fee guarantee.

A clean, all-inclusive flat-price shop — $179/mo semaglutide, $249/mo tirzepatide, unlimited follow-ups included — with no brand-name fallback and no published time-to-first-dose.

$183/mo semaglutide or $268/mo tirzepatide, with quarterly labs and coaching genuinely bundled in, four named pharmacies, and no live video visit described anywhere in its published intake — one of the better-documented options for a working mom's calendar, though pricier than the rock-bottom tiers.